Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A new approach to an individualized therapeutic concept for diabetic patients with atherosclerosis

23.08.2018

Scientists at the Medical Faculty of the Otto-von-Guericke-University Magdeburg (OVGU)identify a new way to straighten out atherosclerotic heart disease in diabetic patients

The major cause of mortality and morbidity among diabetic patients is atherosclerosis and its associated complications like myocardial infarction, stroke, and peripheral vascular disease. While the more aggressive disease progression of atherosclerosis in diabetic patients is established, the underlying mechanisms remain obscure, hampering specific therapeutic approaches to atherosclerosis in diabetic patients.


Diabetes mellitus (DM) and the associated hyperglycaemia cause an increase of the redox-protein p66Shc and reactive oxygen species (ROS) in macrophages, causing instable plaques, which predisposes diabetic patients to myocardial infarction. These effects are counteracted by the cytoprotective effects of the coagulation protease activated protein C (aPC). Human torso reflecting myocardial infarction symptoms is taken from https://smart.servier.com

A hallmark of diabetes-associated atherosclerosis is the perpetuated disease progression despite marked improvement of blood glucose. The sustained disease progression despite improved blood glucose is known as the hyperglycaemic memory – a phenomenon that is equally disappointing and discouraging for patients and doctors.

Scientists led by Prof. Dr. Berend Isermann and Dr. Khurrum Shahzad of the Institute for Clinical Chemistry and Pathobiochemistry at the OVGU and the Magdeburg Health Campus Immunology, Infectiology and Inflammation (GC-I³), unravelled now a new mechanism underlying the hyperglycaemic memory.

They established that in macrophages, inflammatory cells accumulating in the atherosclerotic plaques, more reactive oxygen species are generated as a consequence of increased expression of a redox regulator protein known as p66Shc. Importantly, this protein is specifically expressed in diabetic atherosclerotic lesions, but not in patients or mice without diabetes.

Furthermore, despite normalization of blood glucose levels, expression of p66Shc and hence generation of reactive oxygen species remained high. This identifies the p66Shc-dependent ROS generation as a new mechanism contributing to an impaired plaque stability in diabetic patients. ROS alters the protein and thus the cell function.

But the scientists did not only identify this new mechanism as a characteristic feature of diabetic atherosclerosis. In addition, they were able to correct p66Shc-dependent ROS generation using several supplementary approaches using in vivo models. Thus, they were able to show that the coagulation protease activated protein C reverses the diabetes-specific changes. This establishes that the newly identified mechanism is therapeutically amendable.

“It is now the challenge to confirm these results in larger clinical studies” says Prof. Isermann. Dr. Shahzad adds “In parallel we will devise ways to tackle this pathway therapeutically”. The researchers hope that these insights will lay ground to an individualized therapeutic concept for diabetic patients with atherosclerosis.

Figure:
Diabetes mellitus (DM) and the associated hyperglycaemia cause an increase of the redox-protein p66Shc and reactive oxygen species (ROS) in macrophages, causing instable plaques, which predisposes diabetic patients to myocardial infarction. These effects are counteracted by the cytoprotective effects of the coagulation protease activated protein C (aPC). Human torso reflecting myocardial infarction symptoms is taken from https://smart.servier.com.

Originalpublikation:

doi:10.1038/s42003-018-0108-5;
https://www.nature.com/articles/s42003-018-0108-5

Kornelia Suske | idw - Informationsdienst Wissenschaft

More articles from Health and Medicine:

nachricht Possible Alzheimer's breakthrough suggested
22.01.2020 | Case Western Reserve University

nachricht Body's natural signal carriers can help melanoma spread
21.01.2020 | University of Eastern Finland

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New roles found for Huntington's disease protein

Crucial role in synapse formation could be new avenue toward treatment

A Duke University research team has identified a new function of a gene called huntingtin, a mutation of which underlies the progressive neurodegenerative...

Im Focus: A new look at 'strange metals'

For years, a new synthesis method has been developed at TU Wien (Vienna) to unlock the secrets of "strange metals". Now a breakthrough has been achieved. The results have been published in "Science".

Superconductors allow electrical current to flow without any resistance - but only below a certain critical temperature. Many materials have to be cooled down...

Im Focus: Programmable nests for cells

KIT researchers develop novel composites of DNA, silica particles, and carbon nanotubes -- Properties can be tailored to various applications

Using DNA, smallest silica particles, and carbon nanotubes, researchers of Karlsruhe Institute of Technology (KIT) developed novel programmable materials....

Im Focus: Miniature double glazing: Material developed which is heat-insulating and heat-conducting at the same time

Styrofoam or copper - both materials have very different properties with regard to their ability to conduct heat. Scientists at the Max Planck Institute for Polymer Research (MPI-P) in Mainz and the University of Bayreuth have now jointly developed and characterized a novel, extremely thin and transparent material that has different thermal conduction properties depending on the direction. While it can conduct heat extremely well in one direction, it shows good thermal insulation in the other direction.

Thermal insulation and thermal conduction play a crucial role in our everyday lives - from computer processors, where it is important to dissipate heat as...

Im Focus: Fraunhofer IAF establishes an application laboratory for quantum sensors

In order to advance the transfer of research developments from the field of quantum sensor technology into industrial applications, an application laboratory is being established at Fraunhofer IAF. This will enable interested companies and especially regional SMEs and start-ups to evaluate the innovation potential of quantum sensors for their specific requirements. Both the state of Baden-Württemberg and the Fraunhofer-Gesellschaft are supporting the four-year project with one million euros each.

The application laboratory is being set up as part of the Fraunhofer lighthouse project »QMag«, short for quantum magnetometry. In this project, researchers...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

„Advanced Battery Power“- Conference, Contributions are welcome!

07.01.2020 | Event News

 
Latest News

New self-assembled monolayer is resistant to air

22.01.2020 | Life Sciences

Ultrafast camera takes 1 trillion frames per second of transparent objects and phenomena

22.01.2020 | Power and Electrical Engineering

Mosquitoes are drawn to flowers as much as people -- and now scientists know why

22.01.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>